DRUGBright Minds Biosciences Inc.

Healthcare
$52.26+2.8% 1Y

The financials

Bright Minds Biosciences Inc. by the numbers

For the full year FY2024, revenue was CAD 30K and net income −CAD 2.8M.

Bright Minds Biosciences Inc. income statement, Q4 2019 against the same quarter a year earlier
Income statementQ4 2019
Net income−CAD 79K
Diluted EPS−CAD 0.19

Biotechnology

Ranks #119 of 196 by RyuScore

Compare peers
PBYI+1.6%
PUMA BIOTECHNOLOGY, INC.
ALT-2.4%
Altimmune, Inc.
OCS+1.3%
Oculis Holding AG
PROK+5.0%
PROKIDNEY CORP.
ACRS+12%
Aclaris Therapeutics, Inc.
EPRX-2.7%
EUPRAXIA PHARMACEUTICALS INC.